Category: Gender Identity Development Service (GIDS)
-
Britain Limits Use of Puberty-Blocking Drugs to Research Only
Britain’s National Health Service announced on Friday that it would limit the use of puberty-suppressing drugs to children enrolled in clinical trials. The change comes as the agency’s pediatric gender services have struggled to keep up with soaring demand. Rating: Transneutral, New York Times, June 9, 2023 (PDF archive)
-
Puberty blockers will not be routinely offered to children at new gender clinics
Puberty-supressing hormones will generally only be commissioned as part of clinical research, NHS England said. Rating: Transneutral, Independent, June 9, 2023 (PDF archive)
-
Less than half in Britain back gender-affirming care for trans teenagers
Britain also ranks low in 30-country poll on support for access to public facilities matching gender identity. Rating: Transneutral, Guardian, June 8, 2023 (PDF archive) (HTML archive)